Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
AI Technology Group Inc. completed an acquisition involving Biomed 360 Solutions Corp. (closed 2025-12-15).
- Action
- acquisition
- Counterparty
- Biomed 360 Solutions Corp.
- Closing
- 2025-12-15
Exact text from the filing
On December 15, 2025, the Corporation completed the acquisition of AVMN. · Consideration: 100 common shares of the Corporation issued to Biomed 360 in exchange for 100 common shares of AVM. · Result: AVMN is now a wholly-owned subsidiary of the Corporation.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
AI Technology Group Inc. entered into Share Exchange Agreement with AVM Biotechnology Inc. valued at Acquisition of 100% of AVMN shares for 100 common shares of Corporation (effective 2025-12-15).
- Action
- entry
- Agreement
- merger
- Counterparty
- AVM Biotechnology Inc.
- Value
- Acquisition of 100% of AVMN shares for 100 common shares of Corporation
- Effective
- 2025-12-15
Exact text from the filing
On December 15, 2025, AI Technology Group Inc. (the “Corporation”) entered into a Share Exchange Agreement as amended hereto with AVM Biotechnology Inc. , a Nevada corporation (“AVMN”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVMN. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVMN in exchange for 100 common shares of the Corporation .
View on SEC.gov